Literature DB >> 5673041

Factors altering the responsiveness of mice to hexobarbital.

E S Vesell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5673041     DOI: 10.1159/000135949

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  8 in total

1.  Comparative effects of adenosine and adenine and guanine nucleotides on drug biotransformation in rats.

Authors:  M Weiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.

Authors:  H K Borys; G B Ingall; R Karler
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

3.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

4.  Androgenic repression of hexobarbitone metabolism and action in Crl:CD-1 (ICR)BR mice.

Authors:  B H Shapiro; S M Szczotka
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  Sexual dimorphism and the effects of the X-linked Tfm locus on hexobarbitone metabolism and action in mice.

Authors:  D K King; B H Shapiro
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

6.  The effect of timing of a single injection on the toxicity of methotrexate in the rat.

Authors:  J English; G W Aherne; V Marks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Alteration in hypnotic effect of pentobarbital following repeated agonistic confrontations in mice.

Authors:  S Ohdo; H Yoshimura; N Ogawa
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Chronopharmacologic aspects of hexobarbital oxidation rate in rats.

Authors:  K Püschel; T Mätzsch; H von Mayersbach
Journal:  Arch Toxicol       Date:  1981-09       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.